Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals
- 12 November 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 22 (17), 2331-2339
- https://doi.org/10.1097/qad.0b013e32831883f9
Abstract
Objectives: The prevalence of HIV infection in older patients (≥50 years) is increasing due to HAART, and new HIV infections in older patients. Some earlier studies suggest that older patients respond differently to HAART than younger patients. The objective of this study is to compare the effectiveness of HAART in older and younger HIV patients. Design: Retrospective analysis of an observational clinical cohort. Methods: Virologic and immunologic response, progression to AIDS and mortality were compared between 670 younger patients (t-test, Kaplan–Meier methods, and multivariate Cox proportional hazards analysis. Results: Compared with younger patients, older patients were more likely to be on nonnucleoside reverse transcriptase inhibitors based versus protease inhibitor based regimens (42 vs. 29%, P < 0.01). Time to HIV-1 RNA virologic suppression was less in older than in younger patients (3.2 vs. 4.4 months, P < 0.01). Immunologic response did not differ by age. Older patients had fewer AIDS-defining opportunistic infections (22 vs. 31%, P < 0.01), but higher mortality (36 vs. 27%, P = 0.04) and shorter survival (25th percentile survivor function 36.2 vs. 58.5 months, P = 0.02) than younger patients. Older age was associated with more rapid virologic suppression [adjusted hazard ratio = 1.33 (1.09–1.63)] and earlier mortality [adjusted hazard ratio = 1.56 (1.14–2.14)]. Nonnucleoside reverse transcriptase inhibitors based regimens were associated with more rapid virologic suppression [adjusted hazard ratio = 1.22 (1.03–1.44)]. Conclusion: Time to virologic suppression after HAART initiation was shorter in older patients, although CD4 response did not differ by age. Older patients had fewer opportunistic infections, but survival was shorter. Our data suggest a need to better understand causes of mortality in older patients.Keywords
This publication has 33 references indexed in Scilit:
- Immunologic and Clinical Responses to Highly Active Antiretroviral Therapy in Patients with HIV Infection Aged >50 YearsClinical Infectious Diseases, 2007
- Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapyHIV Medicine, 2007
- Antiretroviral treatment and age‐related comorbidities in a cohort of older HIV‐infected patientsHIV Medicine, 2006
- Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older AdultsJournal of the American Geriatrics Society, 2006
- HIV and AgingDrugs & Aging, 2006
- Older age and plasma viral load in HIV-1 infectionAIDS, 2004
- Medication adherence in HIV-infected adultsAIDS, 2004
- Older age and plasma viral load in HIV-1 infectionAIDS, 2004
- Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitutionThe Lancet, 2000
- Human Immunodeficiency Virus Type 1 Infection: Relationship of Risk Group and Age to Rate of Progression to AIDSThe Journal of Infectious Diseases, 1995